This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Europe’s pharmaceuticalpackaging and labelling market is projected to reach $35.78 billion in 2022, the pharmaceuticalpackaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent between the forecast period: 2023 and 2028. Having been valued at $27.04
In addition, over the next five years, the global pharmaceutical market is projected to grow at a CAGR of 4.7%, with global drug sales anticipated to raise revenues worth USD 1.5 trillion in 2023. 3] Some of the advantages offered by pharmaceutical secondary packaging have been depicted below.
Of course, this calls for a cup of stimulation, and we are opening a new package of pecan pie for the occasion. pharmaceutical industry fell last month, although the number of job cuts remains well above what was seen at the same time in 2023, according to Challenger, Gray & Christmas, the outplacement and executive coaching firm.
The Janssen PharmaceuticalCompanies of Johnson & Johnson has changed its name to Johnson & Johnson Innovative Medicine (J&J Innovative Medicine). This new re-brand for the company follows the appointment its new Executive Vice President, Pharmaceuticals, R&D, an ex- Sanofi executive, in February 2023.
While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing Practice (GMP) Annex 1 effectively reset the benchmark for quality standards across the globe on 25 August 2023. Register your details to read more The post How ready are you?
Revised for 2023, the Parenteral Drug Association (PDA) has published an update to its Technical Report No. 43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for Pharmaceutical Manufacturing.
This calls for celebration with a cup of stimulation, and we are opening a new package of salted caramel for the occasion. This was also well above the 783 jobs the industry slashed in August 2023. What is upon us right now, however, is our ever-growing to-do list. Sound familiar? So here are some items of interest.
Sandoz announced plans for the facility in March 2023. Once completed, the 40,000-square-metre centre will be used to produce active pharmaceutical ingredients (API) for biosimilars in Sandoz’s rheumatology, oncology and immunology portfolio. The site employs 775 people full time, Sandoz said.
“approval [of Pyzchiva ® (biosimilar ustekinumab)] of is a crucial step towards offering European patients an additional safe and effective treatment option” Pharmaceuticalcompany Sandoz has announced that the European Commission (EC) has granted marketing authorisation for Pyzchiva ® (biosimilar ustekinumab ).
LSIMF’s grant provides Kindeva with a “springboard” to partner with leading pharmaceuticalcompanies around the world to bring the next generation of green inhalers to market, according to Kindeva’s Global Chief Commercial Officer David Stevens.
This concerns the quantity of the medicinal product in the packaging, ie, the increase or decrease in the number of units of the product in the outer packaging according to local demands and its labelling, including the leaflet, which should be in the language of the country into which the product is imported.
The ERA therefore needs teeth – which does not mean it should be a barrier to the authorisation of new medicines – but it should require pharmaceuticalcompanies to minimise harmful effects on the environment, which indirectly also harm our health. Strengthening sustainability in the pharmaceutical sector. European Commission.
Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceuticalcompanies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).
In a survey conducted by The European Consumer Organisation (BEUC) during June and July 2022, in Belgium, Italy, Portugal and Spain, 79 percent of consumers said paper leaflets should be available inside the package even if there is an alternative QR code on it. References European Commission, (26 April 2023). Article 63 PGEU (2023).
We revisit a favorite topic, sustainability—and will be updating our coverage of this topic with the upcoming March-April 2023 issue of Pharmaceutical Engineering. It is the result of more than two years of collaboration between the company corporate teams, individual site teams, and an external specialist consultant.
Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceuticalcompanies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).
By GlobalData Learn more about Strategic Intelligence In light of the approvals of Leqembi and Kisunla, large pharmaceuticalcompanies are increasingly investing in Alzheimer’s disease through high-value acquisitions. Stay proactive with real-time data and expert analysis.
As such there’s a growing question of how the industry will improve the sustainability profile of its existing medicines and ensure that sustainability is designed into new medicines, such as products, with a reduced environmental risk, greener manufacturing technologies, and recyclable delivery systems and packaging.
Innovator oligonucleotide-based drugs targeting central nervous system (CNS) indications witnessed a 339% ($2.17bn) increase in total licensing agreement deal value from 2023 to 2024, reaching a total deal value of $2.81bn, according to GlobalData’s Pharma Intelligence Center Deals Database. Credit: Kateryna Kon via Shutterstock.
APAC Pharma Challenges — The Viseven Event Summary, April 2023 Digital maturity, personalized customer engagement, and data-driven marketing have been accepted and implemented in Europe and the US for a few years. However, it’s not the case for most pharma companies in the Asia-Pacific region.
Some of their thoughts are: Mr. Mekala Rao (Chairman – Technology Global PHT Expo & Summit – 2023 and President – Atachi Systems, USA) – “motivation to attend Global PHT is to understand the cultural gap in the production of innovative medicine, healthcare systems between eastern and western world.
The patent protection for Nexplanon typically prevents other pharmaceuticalcompanies from creating a generic version until the patent expires. intrauterine device of brand-name Skyla See latest prices Heather (norethindrone) $46 per 1 package of 28, 0.35 mg tablets $5 per 1 package of 28, 0.35
Take Action for Inhaler Recycling (AIR) was delivered alongside the University Hospitals Leicester NHS Trust and Leicestershire and Rutland Local Pharmaceutical Committee as the first scheme to allow patients to recycle their inhalers through the post. 2023; 11 (17), 6510-6522. 2023; 33:5. 2023; 33(1): 24. Cited 2024Nov].
Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceutical manufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.
The parties that benefit are the pharmaceuticalcompanies and the pharmacies. The losers are patients, insurance companies and the country as a whole for wasting money on unneeded things. Medications are expensive, and some people throw them away after a year, even though they still might be good.
The support from venture capitalists and big pharmaceuticalcompanies will continue to drive the development of circular RNA therapeutics and RNA therapeutics market growth over the forecast period. Considering the potential of these therapies, several industry stakeholders are actively engaging in the development of such therapeutics.
CMC Requirements for New Drug Registration in Latin America Trudy Patterson Tue, 05/09/2023 - 11:23 Features May / June 2023 CMC Requirements for New Drug Registration in Latin America Aicha Otmani Flavia C. Most markets accept COAs from the registration batches (pilot or commercial scale) or commercial batches, if available.
Sustainability: Corporate Ambition, Governance, & Accelerated Delivery Trudy Patterson Tue, 03/07/2023 - 09:14 Features March / April 2023 Sustainability: Corporate Ambition, Governance, & Accelerated Delivery Guy Wingate, PhD Ylva Ek Patricia M. The risks are equally applicable to both privately owned and publicly traded companies.
Challenges for Net Zero Carbon Pharmaceutical Manufacturing Trudy Patterson Mon, 03/06/2023 - 12:40 Features March / April 2023 Challenges for Net Zero Carbon Pharmaceutical Manufacturing Keith M. This study showed that only 9% of the companies currently have targets aligned with a 1.5°C Finalized 9 August 2021.
Our team at PharmaShots has summarized 16 key events of the biosimilar space of May 2023 1. based on change from baseline on a standardized DAS28-CRP which evaluates the severity of RA using clinical and laboratory data Additionally, the company initiates PK study for AVT05 in Jan 2023. 84% vs 64%) & 2yr. (60%
Additionally, this can be caused by “poor handling, repackaging, and nonadherence to good manufacturing practices [GMP] during dispensing and packaging have resulted in the microbiological contamination of non-sterile pharmaceutical products.” Ahmed et al.
According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.
In the 1990s, generic pharmaceuticalcompanies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. The European Commission plans to launch its revised EU pharmaceuticalpackage in Q1 2023 to ease drug shortages,” she says.
FDA Inspections Suspended: During the COVID pandemic, the Food and Drug Administration suspended its inspections at most foreign pharmaceutical facilities. The same was true of another of the company’s products, Delsam Pharma Artificial Eye Ointment , which the company voluntarily recalled shortly after.
Follow package instructions. Follow package directions for each supplement. Sleep issues: I like to recommend Epsom salt baths, which contain magnesium that is absorbed through the skin (1 cup of salts per tub – follow package instructions, and don’t overdo it!), link] December 17, 2017 Accessed August 4, 2023.;
In this last 2022 edition of the series, which started in June , Pharmaceutical Technology is tracking major trial announcements and decisions by regulators and reimbursement agencies that have occurred since mid-October, as well as their potential impact on manufacturing plans. Iomab-B met the durable complete remission endpoint.
9 As such, major investment is warranted for pharmaceuticalcompanies to fully capitalize on the benefits of CM, and they need to make the hard business choice of investing time and money—with added risk—to widen their manufacturing portfolio versus putting money in established technologies that have been profitable. Zydney, and J.
An Evaluation of Postapproval CMC Change Timelines Trudy Patterson Sun, 09/10/2023 - 11:22 Features September / October 2023 An Evaluation of Postapproval CMC Change Timelines Rob Harris, PhD Meike Vanhooren Kara Follmann, PhD Beth Kendsersky Timothy J.N. WHO Expert Committee on Specifications for Pharmaceutical Preparations.”
In an interview with Fox News in 2023, Robert F Kennedy (RFK) Jr said: “Autism comes from vaccines.” Robert Barrie June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook RFK Jr has embarked on a mission to reset vaccine regulation and evidence generation in the US. Credit: Novikov Aleksey via Shutterstock.
It feels like in the US, pharmaceuticalcompanies are capitalising on people’s frustration and desperation to lose weight.” Telehealth platforms selling compounded GLP-1RAs flourished in 2023 and 2024 amid shortages of semaglutide and later tirzepatide. Mochi Health is even the subject of a lawsuit initiated by Eli Lilly.
Go deeper with GlobalData Reports Future of Pharma - Looking Ahead to 2023 Reports China Contract Manufacturing Market Outlook - Trends, Ambitions, Ke. Find out more The pharmaceutical sector is at the cornerstone of the BTA. Data Insights The gold standard of business intelligence.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content